| scholarly article | Q13442814 |
| P2093 | author name string | Hao Liu | |
| Jian Wang | |||
| Min Deng | |||
| Min Liang | |||
| Xin Fu | |||
| Zhimin He | |||
| Boyun Shi | |||
| Xinke Zhou | |||
| Yuqin Chen | |||
| Jitao Chen | |||
| Gao Yi | |||
| Jifang Liu | |||
| Liangcai Chen | |||
| P2860 | cites work | Metformin | Q22250907 |
| Recent developments in targeting carbonic anhydrase IX for cancer therapeutics | Q27013023 | ||
| Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysis | Q27306002 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption | Q28300415 | ||
| The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin | Q28590162 | ||
| Purification and characterization of hypoxia-inducible factor 1 | Q28678375 | ||
| Targeting hypoxia in cancer therapy | Q29615491 | ||
| Metformin and reduced risk of cancer in diabetic patients | Q29616275 | ||
| Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. | Q34114761 | ||
| Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. | Q34182185 | ||
| Metformin in cancer prevention and therapy | Q34357983 | ||
| Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells | Q34487968 | ||
| Effects of metformin on CD133+ colorectal cancer cells in diabetic patients | Q35053962 | ||
| Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation | Q35120687 | ||
| Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis | Q35333423 | ||
| Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response | Q35600122 | ||
| Targeting AMPK for cancer prevention and treatment | Q35781311 | ||
| Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy | Q36007805 | ||
| AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell | Q36214450 | ||
| mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome | Q37256834 | ||
| Diabetes, metformin, and breast cancer in postmenopausal women | Q37303867 | ||
| Regulation of oxygen homeostasis by hypoxia-inducible factor 1. | Q37443475 | ||
| Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling | Q37474343 | ||
| Hypoxia and hypoxia-inducible factors: master regulators of metastasis | Q37801762 | ||
| AMP-activated protein kinase and metabolic control | Q37864217 | ||
| Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. | Q38243373 | ||
| Crosstalk between Mdm2, p53 and HIF1-α: distinct responses to oxygen stress and implications for tumour hypoxia | Q38247162 | ||
| Metformin: from mechanisms of action to therapies | Q38279824 | ||
| Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma | Q38942795 | ||
| Enhanced cytotoxic effect of low doses of metformin combined with ionizing radiation on hepatoma cells via ATP deprivation and inhibition of DNA repair | Q39306592 | ||
| GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis | Q39872802 | ||
| Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels | Q42809789 | ||
| Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response | Q44362277 | ||
| Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway | Q47685710 | ||
| Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo. | Q54631030 | ||
| Use of oral antidiabetic drugs (metformin and pioglitazone) in diabetic patients with breast cancer: how does it effect serum Hif-1 alpha and 8Ohdg levels? | Q85659129 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| hypoxia | Q105688 | ||
| P304 | page(s) | 873-884 | |
| P577 | publication date | 2015-11-28 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma | |
| P478 | volume | 7 |
| Q91965753 | A Humanized Bone Niche Model Reveals Bone Tissue Preservation Upon Targeting Mitochondrial Complex I in Pseudo-Orthotopic Osteosarcoma |
| Q26739665 | A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers |
| Q58585335 | Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption |
| Q64968851 | Asparagus Polysaccharide Suppresses the Migration, Invasion, and Angiogenesis of Hepatocellular Carcinoma Cells Partly by Targeting the HIF-1α/VEGF Signalling Pathway In Vitro. |
| Q49554456 | Disruption of Hif-1α enhances cytotoxic effects of metformin in murine squamous cell carcinoma |
| Q38685135 | Hypoxia inducible factors in hepatocellular carcinoma |
| Q110012860 | Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1 |
| Q61813755 | Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell line |
| Q55262517 | Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response. |
| Q38829871 | Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification |
| Q33914014 | Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells. |
| Q39262741 | Mitochondrial Reactive Oxygen Species and Kidney Hypoxia in the Development of Diabetic Nephropathy |
| Q47160346 | Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer |
| Q59138314 | Pleiotropic Effects of Metformin on Cancer |
| Q26752651 | Repurposing metformin for cancer treatment: current clinical studies |
| Q41921861 | Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine |
| Q64119577 | Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin |
| Q93163927 | Role of purines in regulation of metabolic reprogramming |
| Q48378601 | Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. |
| Q41339882 | Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials |
| Q91981044 | The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma |
Search more.